Q1 2024 Holdings
Filed 2024-05-14 | 63 holdings | $378.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-08-09) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $37.5M | 3,553,844 | 9.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $29.0M | 619,789 | 7.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $26.2M | 1,100,988 | 6.9% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $21.9M | 2,205,899 | 5.8% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $20.3M | 627,228 | 5.4% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $18.9M | 2,965,721 | 5.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $18.2M | 1,547,141 | 4.8% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $17.1M | 1,003,916 | 4.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $13.8M | 1,161,060 | 3.6% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $13.7M | 2,017,016 | 3.6% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $11.7M | 15,067 | 3.1% |
| Merus N V | COM | N5749R100 | $10.5M | 233,871 | 2.8% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $9.8M | 140,267 | 2.6% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $9.3M | 1,848,582 | 2.5% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $8.1M | 222,253 | 2.1% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $7.6M | 1,794,195 | 2.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $7.4M | 272,448 | 2.0% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $6.3M | 274,219 | 1.7% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $6.1M | 269,548 | 1.6% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $5.6M | 740,877 | 1.5% |
| Immatics N.v(IMTX) | SHS | N44445109 | $5.2M | 491,926 | 1.4% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $5.0M | 115,833 | 1.3% |
| Acelyrin Inc | COM | 00445A100 | $4.8M | 714,773 | 1.3% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $4.6M | 121,642 | 1.2% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $4.6M | 83,461 | 1.2% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $4.6M | 90,647 | 1.2% |
| Annexon Inc(ANNX) | COM | 03589W102 | $4.3M | 605,117 | 1.1% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $3.8M | 407,108 | 1.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $3.8M | 87,393 | 1.0% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $3.8M | 129,211 | 1.0% |
| Avadel Pharmaceuticals PLC | COM | G29687103 | $3.8M | 223,660 | 1.0% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $3.7M | 60,129 | 1.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $3.1M | 1,087,785 | 0.8% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $2.7M | 230,273 | 0.7% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $2.4M | 62,253 | 0.6% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $2.1M | 200,000 | 0.5% |
| Effector Therapeutics Inc(EFTR) | COM NEW | 28202V207 | $1.9M | 132,793 | 0.5% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $1.9M | 80,334 | 0.5% |
| CG Oncology Inc(CGON) | COM | 156944100 | $1.8M | 40,723 | 0.5% |
| Achilles Therapeutics PLC(698) | SPONSORED ADS | 00449L102 | $1.7M | 1,385,750 | 0.5% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $1.6M | 26,893 | 0.4% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $1.3M | 43,456 | 0.3% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $1.1M | 51,126 | 0.3% |
| Cabaletta BIO Inc(CABA)Put | COM | 12674W109 | $1.1M | 500,000 | 0.3% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $1.0M | 41,000 | 0.3% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $876.0K | 1,200,000 | 0.2% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $675.5K | 168,442 | 0.2% |
| Arcutis Biotherapeutics Inc(ARQT)Put | COM | 03969K108 | $515.6K | 825,000 | 0.1% |
| Immunovant Inc(IMVT)Call | COM | 45258J102 | $318.8K | 250,000 | 0.1% |
| Merus N VPut | COM | N5749R100 | $212.5K | 85,000 | 0.1% |